To determine the impact of SAAs on BBB dysfunction post-stroke, C57/BL6 male mice underwent MCAo and were injected with 2% Evans blue as a marker for BBB penetration and permeability 30 minutes prior to euthanization (Fig. 6D). This evidence concerns the gene PCSK1N and stroke disorder.